Cerebral ischemia probably related to isotretinoin

Annals of Pharmacotherapy

Volumn 41, Issue 6, 2007, Pages 1073-1076

  Laroche, Marie Laure ^a   Macian Montoro, Francisco ^a   Merle, Louis ^a   Vallat, Jean Michel ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Cerebral ischemia; Isotretinoin

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; HEPARIN; ISOTRETINOIN; ANTITHROMBOCYTIC AGENT; DERMATOLOGICAL AGENT;

ACNE; ADULT; ARTICLE; BLOOD CLOTTING; BRAIN ISCHEMIA; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG WITHDRAWAL; DYSARTHRIA; FACIAL NERVE PARALYSIS; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; PROBABILITY; RATING SCALE; RIGHT HANDEDNESS; RISK FACTOR; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER;

ADULT; ASPIRIN; BRAIN ISCHEMIA; DERMATOLOGIC AGENTS; DIPYRIDAMOLE; HEPARIN; HUMANS; ISOTRETINOIN; MALE; PLATELET AGGREGATION INHIBITORS;

EID: 34250209468     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K028     Document Type: Article

References (30)

1. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology 1998;196:140-7.
2. Bickers DR, Saurat JH. Isotretinoin: a state-of-the-art conference. J Am Acad Dermatol 2001;45:S125-8.
3. Farrell LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial. J Am Acad Dermatol 1980;3:602-11.
4. De Groot AC. Dermatological drugs, topical agents and cosmetics. In: Dukes MNG, Aronson JK, eds. Meyler's side effects of drugs. 14th ed. Amsterdam: Elsevier, 2000:449-52.
5. DRUGDEX. Greenwood Village, CO: Thomson Micromedex. Edition expires 12/2007.
6. Marroni M, Bellomo G, Bucaneve G, Stagni G, Baldelli F. Isotretinoin: possible cause of acute seizure and confusion. Ann Pharmacother 1993; 27:793-4.
7. Pritchard J, Appleton R, Howard R, Hughes RAC. Guillain-Barré syndrome seen in users of isotretinoin. BMJ 2004;328:1537. DOI 10.1136/bmj.328.7455.1537
8. Modan B, Wagener DK. Some epidemiological aspects of stroke: mortality/morbidity trends, age, sex, race, socio-economic status. Stroke 1992;23:1230-6.
9. Recommendations on stroke prevention, diagnosis and therapy. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke 1989;20:1407-31.
10. Jain KK. Drug-induced neurological disorders. 2nd ed. Seattle: Hogrefe and Huber, 2001.
11. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
12. Springuel P, Roy G. Isotretinoin (Accutane): myocardial infarction, cerebrovascular and thromboembolic disorders. Can Adverse Reaction News 2006;16(2):3.
13. Ikeda Y, Yoshinaga K, Iki S, Ohbayashi Y, Urabe A. Acute promyelocytic leukaemia (APL) resulting in broad cerebral infarction during all-trans retinoic acid (ATRA) treatment. Rinsho Ketsueki 1994;35:183-7.
14. Hashimoto S, Koike T, Tatewaki W, et al. Fatal thromboembolism in acute promyelocytic leukaemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia 1994;8:1113-5.
15. Saitoh E, Sugita K, Kurosawa H, et al. Cerebral infarction in acute promyelocytic leukaemia at initial presentation. Acta Paediatr Jpn 1995;37: 710-2.
16. Myoshi T, Otsuki T, Omine K, et al. Acute promyelocytic leukemia accompanied by retinoic acid syndrome with complications of acute myocardial infarction and cerebral infarction during treatment with all-trans retinoic acid. Rinsho Ketsueki 2002;43:954-9.
17. Escudier SM, Kantarjian HM, Estey EH. Thrombosis in patients with acute promyelocytic leukaemia treated with and without all-trans retinoic acid. Leuk Lymphoma 1996;20:435-9.
18. Lee JY, Mak CP, Wang BJ, Chang WC. Effects of retinoids on endothelial cell proliferation, prostacyclin production and platelet aggregation. J Dermatol Sci 1992;3:157-62.
19. Georgala S, Schulpis KH, Potouridou I, Papdogeorgaki H. Effects of isotretinoin therapy on lipoprotein (a) serum levels. Int J Dermatol 1997; 36:863-4.
20. DeRose JJ Jr, Madigan J, Umana JP, et al. Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc Surg 1999;7:633-9.
21. Amalfitano G, Pernod G, Mallaret M, et al. Risk of intracerebral hematoma and profibrinolytic activity of isotretinoin. Therapie 1995;50:479-81.
22. Kooistra T, Opdenberg JP, Toet K, et al. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cell and rat tissues in vivo. Thromb Haemost 1991;65:565-72.
23. Pernod G, Amalfitano G, Le Magueresse B, Berger F, Polack B, Kolodie L. Retinoid induced t-PA synthesis by C6 glioma cells: role in tumoral haemorrhagic necrosis. Thromb Haemost 1996;75:332-8.
24. Gornicki A, Gutsze A. In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity. Eur J Pharmacol 2001;423:127-34.
25. Gornicki A. Influence of the retinoid acitretin on erythrocyte microrheology in vitro. Int J Clin Pharmacol Ther 2006;44:648-54.
26. Lestringant GG, Frossard PM, Agarwal M, Galadari IH. Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol. Int J Dermatol 1997;36:859-62.
27. Moeller KE, Touma SC. Prolonged thrombocytopenia associated with isotretinoin. Ann Pharmacother 2003;37:1622-4. DOI 10.1345/aph.1D098
28. Aurousseau MH, Levacher S, Beneton C, Blaise M, Pourriat JL. Transient dysfibrinogenemia and thrombocytopenia associated with recurrent acute pancreatitis in the course of isotretinoin therapy. Rev Med Interne 1995;16:622-5.
29. Dwyer JM, Kenicer K, Thompson BT, et al. Vasculitis and retinoids. Lancet 1989;2:494-6.
30. Barth JH, Macdonald-Hull SP, Mark J, Jones RG, Cunliffe WJ. Isotretinoin therapy for acne vulgaris: a reevaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129:704-7.